MedinCell S.A.
MEDCL.PA · PAR
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | €419,056 | €456,305 | €281,690 |
| - Cash | €19,472 | €59,040 | €31,636 | €19,460 |
| + Debt | €52,645 | €58,756 | €59,605 | €58,961 |
| Enterprise Value | – | €418,772 | €484,274 | €321,191 |
| Revenue | €11,608 | €16,106 | €9,435 | €3,765 |
| % Growth | -27.9% | 70.7% | 150.6% | – |
| Gross Profit | €0 | €16,106 | €9,435 | €3,436 |
| % Margin | 0% | 100% | 100% | 91.3% |
| EBITDA | -€14,797 | -€3,941 | -€7,259 | -€11,551 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |
| Net Income | -€16,078 | -€3,870 | -€14,568 | -€16,880 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS Diluted | -0.49 | -0.12 | -0.5 | -0.58 |
| % Growth | -308.3% | 76% | 13.8% | – |
| Operating Cash Flow | -€14,253 | -€2,845 | €21,559 | -€163 |
| Capital Expenditures | -€230 | -€552 | -€195 | -€172 |
| Free Cash Flow | -€14,483 | -€3,397 | €21,364 | -€335 |